Fosun Pharma won the 6th Shanghai Innovative Enterprise Award for Science and Technology
Founded in 1994, Fosun Pharma (SH: 600196, HK: 02196) is a leading listed company in China’s pharmaceutical industry, which began listed in Shanghai Stock Exchange in August 1998 and HK Exchange in October 2012.
Since it founded, Fosun Pharma has been adhering to innovation, from original invention to improvement of applied technology and from management optimization to service innovation, to make contribution to public health. Upholding the brand philosophy of Innovation for Good Health, Fosun Pharma keeps investment of independent R&D, trying to make original breakthrough in the important therapeutic field; it is committed to improving generic drugs and providing patients with safe, reliable and effective drugs; it carries out ongoing management optimization and service innovation to constantly enhance its health service and management level.
Fosun Pharma continues to improve R&D teams on generic and innovative drugs and established the unique 4+1 R&D platform with fruitful results: By the end of Jun.30th,2012, the company owns 220 patents, including 106 invention patents, 35 utility model patents and 79 design patents. The company also has over 100 products under progress.
Over the years, the innovation efforts and achievements of Fosun Pharma have won recognition and support by national and Shanghai municipal departments, National Validated Enterprise Technology Center and National High-tech Industrialization Demonstration Project by National Development and Reform Committee, Innovative Enterprise by five ministries including Ministry of Science and Technology are among parts of its innovation related awards and honors